drugset / Trial / NCT04303806
Effect of Rosuvastatin on the Clinical Features of Preeclampsia
RandomizedParallel-groupDouble-blindOther
Summary
The primary outcome will be the effect of rosuvastatin on the resolution of biochemical features associated with severe PE (↑CRP and IL6). .
Timeline
- Start
- 2020-10
- Primary completion
- 2022-10
- Completion
- 2023-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosuvastatin | Small molecule | 20 mg | Oral |
| Subject | Rosuvastatin | Small molecule | 40 mg | Oral |